|1.||Popova, E V: 2 articles (07/2002 - 07/2001)|
|2.||Dubrovina, N I: 2 articles (07/2002 - 07/2001)|
|3.||Hawkins, Robert D: 1 article (10/2013)|
|4.||Bardoni, Rita: 1 article (09/2013)|
|5.||Loboda, Yelena: 1 article (02/2013)|
|6.||Finberg, John P M: 1 article (02/2013)|
|7.||Vaya, Jacob: 1 article (02/2013)|
|8.||Aluf, Yuval: 1 article (02/2013)|
|9.||Khatib, Soliman: 1 article (02/2013)|
|10.||Shoji, Masaru: 1 article (01/2012)|
|1.||Schizophrenia (Dementia Praecox)
06/01/1996 - "The enhancement of DA function produced by its selective presynaptic receptor DA blockade may account for the clinical efficacy of amisulpride against negative symptoms of schizophrenia."
10/01/2013 - "Thus, presynaptic receptors and spontaneous release may contribute to postsynaptic mechanisms of plasticity in brain regions involved in reward and memory, and could play roles in disorders that affect plasticity in those regions, including addiction, Alzheimer's disease, schizophrenia, and attention deficit hyperactivity disorder (ADHD). "
12/01/1982 - "If low doses of pergolide can reduce dopaminergic transmission by activating presynaptic receptors that control dopamine release, then this action might be therapeutically useful in treating schizophrenia without causing tardive dyskinesia or in the treatment of tardive dyskinesia. "
11/01/2004 - "At the 8th World Congress on Clinical Pharmacology and Therapeutics, held August 1-6, 2004, in Queensland, Australia, there were late-breaking news symposia on presynaptic receptors as targets in the treatment of schizophrenia; cyclooxygenase inhibition, present and future; adiposity, drug treatment and causes; G-protein-coupled receptors, important new targets; osteoporosis, causes, prevention and cures; ischemic stroke; drugs and arrhythmias, causes and cures; and the pharmacology of cardiac protection. "
|2.||Hypertension (High Blood Pressure)
01/01/1990 - "Presynaptic receptors in hypertension."
07/01/1991 - "6. This article summarizes the results of studies to evaluate presynaptic receptor functions and sympathetic neurotransmitter release in hypertension."
09/01/1992 - "Drugs that inhibit noradrenaline release through stimulation of inhibitory receptors located at adrenergic nerve terminals in the cardiovascular system (inhibitory presynaptic receptors) are not available for the treatment of hypertension. "
|3.||Septic Shock (Toxic Shock Syndrome)
06/01/2004 - "1. Our study was undertaken to investigate whether bacterial endotoxin/lipopolysaccharide (LPS) affects the neurogenic vasopressor response in rats in vivo by presynaptic mechanisms and, if so, to characterize the type of presynaptic receptor(s) operating in the initial phase of septic shock. "
|4.||Raynaud Disease (Raynaud's Disease)
06/01/1989 - "The present study confirms that the principal role in the physiopathologic progression of Raynaud's disease seems to be played by a modification of the beta-presynaptic receptors in the nerve endings of the peripheral vessels."
06/01/1989 - "Flunarizine reinforces the action of atenolol in causing a decrease in vasoconstriction in patients with Raynaud's disease, as observed previously by us, in that it acts directly on the beta-presynaptic receptors or on the calcium slow channels connected to the beta-receptors. "
|5.||Ganglion Cysts (Ganglion)
01/01/1992 - "The modulation of evoked transmitter release by presynaptic receptors was studied at an identified cholinergic synapse in the buccal ganglion of Aplysia. "
06/01/1986 - "Nine identified interneurons that originate in the 6th abdominal ganglion were studied with intracellular techniques while activating the receptors presynaptic to them with coherent water vibrations of precisely controlled amplitude and frequency. "
12/13/1993 - "DOR-1-ir ganglion neurons were also immunoreactive for calcitonin gene-related peptide (CGRP), and their terminals in the spinal cord contained both CGRP- and DOR-1-ir, the latter presumably located as a 'presynaptic' receptor. "
03/01/1993 - "Transmitter release and calcium currents at an Aplysia buccal ganglion synapse--II. Modulation by presynaptic receptors."
04/01/1988 - "The possible involvement of cholinergic presynaptic receptors regulating evoked quantal acetylcholine (ACh) release was investigated at an identified cholinergic neuro-neuronal synapse in the buccal ganglion of Aplysia, using cholinergic agonists (carbachol, pilocarpine, oxotremorine) and/or antagonists (curare, atropine, hexamethonium). "
|2.||Neurotransmitter Agents (Neurotransmitter)
|7.||Acetylcholine (Acetylcholine Chloride)
|8.||G-Protein-Coupled Receptors (Receptors, G Protein Coupled)
|9.||Hexamethonium (Hexamethonium Bromide)
|10.||Glutamic Acid (Glutamate)
|1.||Investigational Therapies (Experimental Therapy)